MediWound Ltd.
MDWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,429 | $5,708 | $3,955 | $5,840 |
| % Growth | -4.9% | 44.3% | -32.3% | – |
| Cost of Goods Sold | $4,533 | $4,366 | $3,217 | $4,937 |
| Gross Profit | $896 | $1,342 | $738 | $903 |
| % Margin | 16.5% | 23.5% | 18.7% | 15.5% |
| R&D Expenses | $3,465 | $3,491 | $2,886 | $2,986 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,956 | $3,567 | $3,073 | $4,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7,421 | $7,058 | $5,959 | $6,986 |
| Operating Income | -$6,525 | -$5,716 | -$5,221 | -$6,083 |
| % Margin | -120.2% | -100.1% | -132% | -104.2% |
| Other Income/Exp. Net | $3,926 | -$7,564 | $4,500 | $2,193 |
| Pre-Tax Income | -$2,599 | -$13,280 | -$721 | -$3,890 |
| Tax Expense | $53 | $38 | $5 | $18 |
| Net Income | -$2,652 | -$13,318 | -$726 | -$3,908 |
| % Margin | -48.8% | -233.3% | -18.4% | -66.9% |
| EPS | -0.24 | -1.23 | -0.07 | -0.36 |
| % Growth | 80.5% | -1,657.1% | 80.6% | – |
| EPS Diluted | -0.24 | -1.23 | -0.067 | -0.36 |
| Weighted Avg Shares Out | 11,022 | 10,835 | 10,372 | 10,791 |
| Weighted Avg Shares Out Dil | 11,022 | 10,835 | 10,798 | 10,791 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,926 | $429 | $4,504 | $2,211 |
| Interest Expense | $0 | $7,993 | $0 | $0 |
| Depreciation & Amortization | $418 | $394 | $358 | $397 |
| EBITDA | -$2,181 | -$4,893 | -$363 | -$3,493 |
| % Margin | -40.2% | -85.7% | -9.2% | -59.8% |